Written question asked by Stuart Andrew (Conservative) on Tuesday, 13 October 2026, in the House of Commons. It was due for an answer on Thursday, 15 October 2026. It was answered by Chris McDonald (Labour) on Wednesday, 21 October 2026 on behalf of the Department for Business, Innovation, Science and Trade.
Kidney Diseases: Research
- Question
-
To ask the Secretary of State for Business, Innovation, Science and Trade, what the cost to the public purse was of Government investment into kidney disease research in 2025-26; and which public bodies provided that investment.
- Answer
-
This Department funds medical research through UK Research and Innovation (UKRI). UKRI’s Medical Research Council (MRC) funds research into the detection, prevention, treatment and underpinning biology of kidney disease.
In financial year 2025–26, the MRC awarded £12.9 million for new research directly focused on kidney disease.
This response only covers MRC funded research. The Department of Health and Social Care (DHSC) funds medical research through the National Institute for Health and Care Research (NIHR). DHSC will separately provide an answer to UIN 34276 to cover NIHR funded research.
Secondary information
- Type
- Written question
- Reference
- 34277
- Session
- 2026-27
- Subjects
- Expenditure Research Kidney diseases
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-10-21 17:51:28 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/34277
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/34277
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2026-27/34277